Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 10,000 shares at $45.02 ($455K) on 2021-02-02, disclosed to the SEC on 2021-02-03.
Open-market sale of $455k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.02 | 8,000 | $360K | 79.2% |
| 2 | $47.19 | 2,000 | $94K | 20.8% |
| Total | $45.45 avg | 10,000 | $455K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |